Washington - The U.S. Drug Enforcement Administration in coordination with federal partners and the People’s Republic of China convened the Bilateral Drug Intelligence Working Group (BDIWG) in Colorado Springs February 10 to 12, 2026. This working group brought together law enforcement, prosecutors, customs, border security, public security, financial supervision, and...

WASHINGTON – Today, the U.S. Drug Enforcement Administration, with the cooperation of the U.S. Attorney’s Office for the Eastern District of New York, announced the seizure of more than 200 website domains tied to an India-based transnational criminal organization (TCO) working within the United States and allegedly responsible for at...

WASHINGTON – 2025 was a year of historic achievements for the U.S. Drug Enforcement Administration highlighted by significant drug seizures, the capture of high-profile targets, and the confirmation of DEA Administrator Terrance C. Cole. Appointed by President Donald Trump on February 11, 2025 and sworn in on July 23, 2025...

SAN FRANCISCO – For a third consecutive year, the U.S. Drug Enforcement Administration and NFL Alumni Health (NFLAH) are joining forces to raise awareness about the dangers of fentanyl and spreading a critical message: One Pill Can Kill . Building on the success of the last two year, this collaboration...

The United States announced today that yesterday evening it took into custody 37 fugitives from Mexico facing a range of federal criminal charges around the country, including charges relating to narcoterrorism, providing material support to a foreign terrorist organization, firearms trafficking, human smuggling, money laundering, and various drug trafficking offenses...

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...

WASHINGTON – As 2022 comes to an end, the Drug Enforcement Administration is announcing the seizure of over 50.6 million fentanyl-laced, fake prescription pills and more than 10,000 pounds of fentanyl powder this calendar year. The DEA Laboratory estimates that these seizures represent more than 379 million potentially deadly doses...

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...

WASHINGTON – This week the Drug Enforcement Administration (DEA) hosted regional family summits across the country in support of those who have lost loved ones to fentanyl poisoning. This is the first undertaking of its kind for the DEA field divisions and builds off the momentum of this summer’s Inaugural...

WASHINGTON – On Oct. 29, 2022, communities across the country demonstrated their continued support for DEA’s bi-annual National Prescription Drug Take Back Day by safely disposing of more than 647,000 pounds of unneeded medications at nearly 5,000 collection sites across the country. Since its inception in 2010, DEA’s National Prescription...